vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $13.8M, roughly 1.7× FENNEC PHARMACEUTICALS INC.). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -34.7%, a 49.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -25.0%). Over the past eight quarters, GENCOR INDUSTRIES INC's revenue compounded faster (-23.9% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
FENC vs GENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $23.6M |
| Net Profit | $-4.8M | $3.4M |
| Gross Margin | — | 28.7% |
| Operating Margin | -18.5% | 13.2% |
| Net Margin | -34.7% | 14.6% |
| Revenue YoY | 73.8% | -25.0% |
| Net Profit YoY | -141.1% | -9.8% |
| EPS (diluted) | $-0.17 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $23.6M | ||
| Q3 25 | $12.5M | $18.8M | ||
| Q2 25 | $9.7M | $27.0M | ||
| Q1 25 | $8.8M | $38.2M | ||
| Q4 24 | $7.9M | $31.4M | ||
| Q3 24 | $7.0M | $20.9M | ||
| Q2 24 | $7.3M | $25.6M | ||
| Q1 24 | $25.4M | $40.7M |
| Q4 25 | $-4.8M | $3.4M | ||
| Q3 25 | $-638.0K | $1.9M | ||
| Q2 25 | $-3.2M | $3.8M | ||
| Q1 25 | $-1.2M | $6.1M | ||
| Q4 24 | $-2.0M | $3.8M | ||
| Q3 24 | $-5.7M | $1.5M | ||
| Q2 24 | $-5.6M | $2.6M | ||
| Q1 24 | $12.8M | $6.2M |
| Q4 25 | — | 28.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 27.6% | ||
| Q3 24 | — | 25.6% | ||
| Q2 24 | — | 23.9% | ||
| Q1 24 | — | 30.3% |
| Q4 25 | -18.5% | 13.2% | ||
| Q3 25 | -1.5% | -1.2% | ||
| Q2 25 | -28.3% | 11.6% | ||
| Q1 25 | -9.2% | 17.0% | ||
| Q4 24 | -11.8% | 14.7% | ||
| Q3 24 | -74.6% | 5.9% | ||
| Q2 24 | -69.4% | 7.8% | ||
| Q1 24 | 54.2% | 17.4% |
| Q4 25 | -34.7% | 14.6% | ||
| Q3 25 | -5.1% | 10.2% | ||
| Q2 25 | -32.7% | 14.2% | ||
| Q1 25 | -13.3% | 16.0% | ||
| Q4 24 | -25.0% | 12.1% | ||
| Q3 24 | -82.2% | 6.9% | ||
| Q2 24 | -76.5% | 10.0% | ||
| Q1 24 | 50.6% | 15.3% |
| Q4 25 | $-0.17 | $0.23 | ||
| Q3 25 | $-0.02 | $0.13 | ||
| Q2 25 | $-0.11 | $0.26 | ||
| Q1 25 | $-0.04 | $0.42 | ||
| Q4 24 | $-0.02 | $0.26 | ||
| Q3 24 | $-0.21 | $0.10 | ||
| Q2 24 | $-0.20 | $0.17 | ||
| Q1 24 | $0.41 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $147.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $215.2M |
| Total Assets | $70.6M | $228.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $147.7M | ||
| Q3 25 | $21.9M | $136.3M | ||
| Q2 25 | $18.7M | $136.0M | ||
| Q1 25 | $22.7M | $143.7M | ||
| Q4 24 | $26.6M | $130.1M | ||
| Q3 24 | $40.3M | $115.4M | ||
| Q2 24 | $43.1M | $116.6M | ||
| Q1 24 | $51.2M | $117.1M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | $0 | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | $0 | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $215.2M | ||
| Q3 25 | $-4.5M | $211.8M | ||
| Q2 25 | $-7.5M | $209.9M | ||
| Q1 25 | $-5.9M | $206.1M | ||
| Q4 24 | $-5.9M | $200.0M | ||
| Q3 24 | $-5.2M | $196.1M | ||
| Q2 24 | $-1.4M | $194.7M | ||
| Q1 24 | $3.0M | $192.1M |
| Q4 25 | $70.6M | $228.9M | ||
| Q3 25 | $49.3M | $222.6M | ||
| Q2 25 | $44.9M | $220.2M | ||
| Q1 25 | $46.4M | $223.9M | ||
| Q4 24 | $44.9M | $218.2M | ||
| Q3 24 | $58.9M | $208.1M | ||
| Q2 24 | $63.2M | $201.8M | ||
| Q1 24 | $69.2M | $206.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $11.1M |
| Free Cash FlowOCF − Capex | — | $10.1M |
| FCF MarginFCF / Revenue | — | 43.0% |
| Capex IntensityCapex / Revenue | — | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.23× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-3.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $11.1M | ||
| Q3 25 | $1.5M | $-275.0K | ||
| Q2 25 | $-3.7M | $-23.9M | ||
| Q1 25 | $-4.3M | $12.4M | ||
| Q4 24 | $-1.5M | $14.8M | ||
| Q3 24 | $-2.2M | $-3.2M | ||
| Q2 24 | $-8.4M | $-1.0M | ||
| Q1 24 | $39.0M | $11.7M |
| Q4 25 | — | $10.1M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $-24.4M | ||
| Q1 25 | — | $12.3M | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $-3.3M | ||
| Q2 24 | — | $-1.4M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | — | 43.0% | ||
| Q3 25 | — | -6.8% | ||
| Q2 25 | — | -90.4% | ||
| Q1 25 | — | 32.2% | ||
| Q4 24 | — | 46.1% | ||
| Q3 24 | — | -15.8% | ||
| Q2 24 | — | -5.6% | ||
| Q1 24 | — | 28.7% |
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | 3.23× | ||
| Q3 25 | — | -0.14× | ||
| Q2 25 | — | -6.24× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | -2.22× | ||
| Q2 24 | — | -0.41× | ||
| Q1 24 | 3.04× | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
